Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Nadia Harbeck, Manfred Schmitt, Stefan Paepke, Heike Allgayer & Ronald E. Kates. (2007) Tumor-Associated Proteolytic Factors uPA and PAI-1: Critical Appraisal of Their Clinical Relevance in Breast Cancer and Their Integration into Decision-Support Algorithms. Critical Reviews in Clinical Laboratory Sciences 44:2, pages 179-201.
Read now
Read now
Articles from other publishers (10)
Maritess Arancillo, Chen-Ming Lin & Kevin Burgess. (2022) Piptide Chemotypes for Perturbation of the Interaction of Urokinase with Its Receptor. Journal of Medicinal Chemistry 65:19, pages 12925-12932.
Crossref
Crossref
Simona Barberi, Giacomo Montagna & Lorenzo Rossi. (2019) Expression of urokinase plasminogen activator (uPA) in the leukocytes and tissues of patients with benign and malignant breast lesions. Breast Disease 38:1, pages 15-23.
Crossref
Crossref
Li Wei, Jin-Shuen Chen, Hsin-Ting Lin, Chung-Ze Wu, Cai-Mei Zheng, Yu-Ching Chang, Li-Chien Chang & Yuh-Feng Lin. (2017) Atorvastatin from target screening attenuates endothelial cell tube formation and migration by regulating urokinase receptor-related signaling pathway and F/G actin. Journal of the Chinese Medical Association 80:2, pages 86-95.
Crossref
Crossref
Anthony V. Rawlings & Rainer Voegeli. (2012) Stratum corneum proteases and dry skin conditions. Cell and Tissue Research 351:2, pages 217-235.
Crossref
Crossref
NatašA Todorovic-Raković, Tijana Vujasinović & Zaki Abu Rabi. (2018) Selection of Clinically useful Angiogenesis-Related Biomarkers: An Update. The International Journal of Biological Markers 27:2, pages 65-81.
Crossref
Crossref
Rainer Voegeli & Anthony V. Rawlings. 2012. Treatment of Dry Skin Syndrome. Treatment of Dry Skin Syndrome
149
178
.
Ladan Teimoori-Toolabi, Kayhan Azadmanesh, Amir Amanzadeh & Sirous Zeinali. (2010) Selective Suicide Gene Therapy of Colon Cancer Exploiting the Urokinase Plasminogen Activator Receptor Promoter. BioDrugs 24:2, pages 131-146.
Crossref
Crossref
Paola Llinas, Marie Hélène Le Du, Henrik Gårdsvoll, Keld Danø, Michael Ploug, Bernard Gilquin, Enrico A Stura & André Ménez. (2005) Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide. The EMBO Journal 24:9, pages 1655-1663.
Crossref
Crossref
AIQUN NIELSEN, CHRISTOPHER J SCARLETT, JASWINDER S SAMRA, ANTHONY GILL, YONG LI, BARRY J ALLEN & ROSS C SMITH. (2005) Significant overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma using real-time quantitative reverse transcription polymerase chain reaction. Journal of Gastroenterology and Hepatology 20:2, pages 256-263.
Crossref
Crossref
Moulay A. Alaoui-Jamali & He Qiang. (2003) The interface between ErbB and non-ErbB receptors in tumor invasion: clinical implications and opportunities for target discovery. Drug Resistance Updates 6:2, pages 95-107.
Crossref
Crossref